E D Kreuser - JoVE Visualize

Showing results (41-50 of 65) with videos related to

Pageof 7

Sort By:

Clinical & Experimental Metastasis|March 26, 1999

Integrin alpha5beta1: a potent inhibitor of experimental lung metastasisM Schirner, F Herzberg, R Schmidt, et al.

British Journal of Cancer|June 2, 2005

Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II studyD Serin, M Verrill, A Jones, et al.

Onkologie|December 9, 2004

Second-line treatment of advanced colorectal cancer with a weekly simultaneous 24-hour infusion of 5-fluorouracil and sodium-folinate: a multicentre phase II trialJ Kuhfahl, C Steinbrecher, T Wagner, et al.

British Journal of Cancer|September 30, 2010

Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-αM Kornmann, L Staib, T Wiegel, et al.

Pancreas|April 1, 1996

Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreasM Löhr, B Trautmann, M Göttler, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001

Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effective therapy for patients with advanced multiple myelomaH Szelényi, E D Kreuser, U Keilholz, et al.

Journal of Perinatal Medicine|January 1, 1996

Successful emergency splenectomy during pregnancy in a patient with life-threatening idiopathic thrombocytopenia. Case reportB Stiemer, F Opri, D Senger, et al.

European Journal of Cancer (Oxford, England : 1990)|July 15, 2004

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancerI J Diel, J-J Body, M R Lichinitser, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1989

Compliance of physicians and patients with a consensus protocol for treatment of advanced breast cancerF Porzsolt, G Meuret, E D Kreuser, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastasesJ-J Body, I J Diel, M R Lichinitser, et al.

Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:

Pageof 7

Clinical & Experimental Metastasis|March 26, 1999

Integrin alpha5beta1: a potent inhibitor of experimental lung metastasisM Schirner, F Herzberg, R Schmidt, et al.

British Journal of Cancer|June 2, 2005

Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II studyD Serin, M Verrill, A Jones, et al.

Onkologie|December 9, 2004

Second-line treatment of advanced colorectal cancer with a weekly simultaneous 24-hour infusion of 5-fluorouracil and sodium-folinate: a multicentre phase II trialJ Kuhfahl, C Steinbrecher, T Wagner, et al.

British Journal of Cancer|September 30, 2010

Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-αM Kornmann, L Staib, T Wiegel, et al.

Pancreas|April 1, 1996

Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreasM Löhr, B Trautmann, M Göttler, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001

Cyclophosphamide, adriamycin and dexamethasone (CAD) is a highly effective therapy for patients with advanced multiple myelomaH Szelényi, E D Kreuser, U Keilholz, et al.

Journal of Perinatal Medicine|January 1, 1996

Successful emergency splenectomy during pregnancy in a patient with life-threatening idiopathic thrombocytopenia. Case reportB Stiemer, F Opri, D Senger, et al.

European Journal of Cancer (Oxford, England : 1990)|July 15, 2004

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancerI J Diel, J-J Body, M R Lichinitser, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1989

Compliance of physicians and patients with a consensus protocol for treatment of advanced breast cancerF Porzsolt, G Meuret, E D Kreuser, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastasesJ-J Body, I J Diel, M R Lichinitser, et al.

Pageof 7